Report Detail
Global Immunosuppressive Drugs Market Insights, Forecast to 2028
- RnM4393679 |
- 10 March, 2022 |
- Global |
- 106 Pages |
- QYResearch |
- Pharma & Healthcare
Summary:
Market Analysis and Insights: Global Immunosuppressive Drugs Market
Due to the COVID-19 pandemic, the global Immunosuppressive Drugs market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Calcineurin Inhibitors accounting for % of the Immunosuppressive Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Kidney Transplant segment is altered to an % CAGR throughout this forecast period.
China Immunosuppressive Drugs market size is valued at US$ million in 2021, while the US and Europe Immunosuppressive Drugs are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Immunosuppressive Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Immunosuppressive Drugs include Pfizer, Sanofi, Novartis, Roche, Astellas Pharma, Inc., GlaxoSmithKline plc, Veloxis Pharmaceuticals, Mylan and Dr Reddys Laboratories and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Market Segments
The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.
Segment by Type
Calcineurin Inhibitors
Antiproliferative Agents
mTOR Inhibitors
Antibodies
Steroids
Segment by Application
Kidney Transplant
Bone Marrow Transplant
Liver Transplant
Heart Transplant
Lungs Transplant
Others Transplant
Consequence of Covid-19 Pandemic
The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Immunosuppressive Drugs market back to the pre-covid levels.
Trends & Prospects
In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Outlook
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Pfizer
Sanofi
Novartis
Roche
Astellas Pharma, Inc.
GlaxoSmithKline plc
Veloxis Pharmaceuticals
Mylan
Dr Reddys Laboratories
Abbvie Inc
Frequently Asked Questions
Which is the most lucrative product segment in the Immunosuppressive Drugs market?
Which are the prominent strategies of the Immunosuppressive Drugs market players?
Which factors are increasing the competition in the Immunosuppressive Drugs market?
Which are the recommendations provided by the Immunosuppressive Drugs industry experts?
Which region will witness rewarding growth during the forecast period?
What factors will curb the Immunosuppressive Drugs market growth?
Which product segment will register the fastest growth rate in the Immunosuppressive Drugs market?
Which emerging trends will impact the Immunosuppressive Drugs market growth?
Which are the high-impact rendering factors in the Immunosuppressive Drugs market?
Which companies will maintain their lead on the Immunosuppressive Drugs market?
Table of Contents
1 Study Coverage
- 1.1 Immunosuppressive Drugs Product Introduction
- 1.2 Market by Type
- 1.2.1 Global Immunosuppressive Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
- 1.2.2 Calcineurin Inhibitors
- 1.2.3 Antiproliferative Agents
- 1.2.4 mTOR Inhibitors
- 1.2.5 Antibodies
- 1.2.6 Steroids
- 1.3 Market by Application
- 1.3.1 Global Immunosuppressive Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
- 1.3.2 Kidney Transplant
- 1.3.3 Bone Marrow Transplant
- 1.3.4 Liver Transplant
- 1.3.5 Heart Transplant
- 1.3.6 Lungs Transplant
- 1.3.7 Others Transplant
- 1.4 Study Objectives
- 1.5 Years Considered
2 Executive Summary
- 2.1 Global Immunosuppressive Drugs Sales Estimates and Forecasts 2017-2028
- 2.2 Global Immunosuppressive Drugs Revenue Estimates and Forecasts 2017-2028
- 2.3 Global Immunosuppressive Drugs Revenue by Region: 2017 VS 2021 VS 2028
- 2.4 Global Immunosuppressive Drugs Sales by Region
- 2.4.1 Global Immunosuppressive Drugs Sales by Region (2017-2022)
- 2.4.2 Global Sales Immunosuppressive Drugs by Region (2023-2028)
- 2.5 Global Immunosuppressive Drugs Revenue by Region
- 2.5.1 Global Immunosuppressive Drugs Revenue by Region (2017-2022)
- 2.5.2 Global Immunosuppressive Drugs Revenue by Region (2023-2028)
- 2.6 North America
- 2.7 Europe
- 2.8 Asia-Pacific
- 2.9 Latin America
- 2.10 Middle East & Africa
3 Competition by Manufacturers
- 3.1 Global Immunosuppressive Drugs Sales by Manufacturers
- 3.1.1 Global Top Immunosuppressive Drugs Manufacturers by Sales (2017-2022)
- 3.1.2 Global Immunosuppressive Drugs Sales Market Share by Manufacturers (2017-2022)
- 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Immunosuppressive Drugs in 2021
- 3.2 Global Immunosuppressive Drugs Revenue by Manufacturers
- 3.2.1 Global Immunosuppressive Drugs Revenue by Manufacturers (2017-2022)
- 3.2.2 Global Immunosuppressive Drugs Revenue Market Share by Manufacturers (2017-2022)
- 3.2.3 Global Top 10 and Top 5 Companies by Immunosuppressive Drugs Revenue in 2021
- 3.3 Global Immunosuppressive Drugs Sales Price by Manufacturers (2017-2022)
- 3.4 Analysis of Competitive Landscape
- 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Immunosuppressive Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4.3 Global Immunosuppressive Drugs Manufacturers Geographical Distribution
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Global Immunosuppressive Drugs Sales by Type
- 4.1.1 Global Immunosuppressive Drugs Historical Sales by Type (2017-2022)
- 4.1.2 Global Immunosuppressive Drugs Forecasted Sales by Type (2023-2028)
- 4.1.3 Global Immunosuppressive Drugs Sales Market Share by Type (2017-2028)
- 4.2 Global Immunosuppressive Drugs Revenue by Type
- 4.2.1 Global Immunosuppressive Drugs Historical Revenue by Type (2017-2022)
- 4.2.2 Global Immunosuppressive Drugs Forecasted Revenue by Type (2023-2028)
- 4.2.3 Global Immunosuppressive Drugs Revenue Market Share by Type (2017-2028)
- 4.3 Global Immunosuppressive Drugs Price by Type
- 4.3.1 Global Immunosuppressive Drugs Price by Type (2017-2022)
- 4.3.2 Global Immunosuppressive Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
- 5.1 Global Immunosuppressive Drugs Sales by Application
- 5.1.1 Global Immunosuppressive Drugs Historical Sales by Application (2017-2022)
- 5.1.2 Global Immunosuppressive Drugs Forecasted Sales by Application (2023-2028)
- 5.1.3 Global Immunosuppressive Drugs Sales Market Share by Application (2017-2028)
- 5.2 Global Immunosuppressive Drugs Revenue by Application
- 5.2.1 Global Immunosuppressive Drugs Historical Revenue by Application (2017-2022)
- 5.2.2 Global Immunosuppressive Drugs Forecasted Revenue by Application (2023-2028)
- 5.2.3 Global Immunosuppressive Drugs Revenue Market Share by Application (2017-2028)
- 5.3 Global Immunosuppressive Drugs Price by Application
- 5.3.1 Global Immunosuppressive Drugs Price by Application (2017-2022)
- 5.3.2 Global Immunosuppressive Drugs Price Forecast by Application (2023-2028)
6 North America
- 6.1 North America Immunosuppressive Drugs Market Size by Type
- 6.1.1 North America Immunosuppressive Drugs Sales by Type (2017-2028)
- 6.1.2 North America Immunosuppressive Drugs Revenue by Type (2017-2028)
- 6.2 North America Immunosuppressive Drugs Market Size by Application
- 6.2.1 North America Immunosuppressive Drugs Sales by Application (2017-2028)
- 6.2.2 North America Immunosuppressive Drugs Revenue by Application (2017-2028)
- 6.3 North America Immunosuppressive Drugs Market Size by Country
- 6.3.1 North America Immunosuppressive Drugs Sales by Country (2017-2028)
- 6.3.2 North America Immunosuppressive Drugs Revenue by Country (2017-2028)
- 6.3.3 United States
- 6.3.4 Canada
7 Europe
- 7.1 Europe Immunosuppressive Drugs Market Size by Type
- 7.1.1 Europe Immunosuppressive Drugs Sales by Type (2017-2028)
- 7.1.2 Europe Immunosuppressive Drugs Revenue by Type (2017-2028)
- 7.2 Europe Immunosuppressive Drugs Market Size by Application
- 7.2.1 Europe Immunosuppressive Drugs Sales by Application (2017-2028)
- 7.2.2 Europe Immunosuppressive Drugs Revenue by Application (2017-2028)
- 7.3 Europe Immunosuppressive Drugs Market Size by Country
- 7.3.1 Europe Immunosuppressive Drugs Sales by Country (2017-2028)
- 7.3.2 Europe Immunosuppressive Drugs Revenue by Country (2017-2028)
- 7.3.3 Germany
- 7.3.4 France
- 7.3.5 U.K.
- 7.3.6 Italy
- 7.3.7 Russia
8 Asia Pacific
- 8.1 Asia Pacific Immunosuppressive Drugs Market Size by Type
- 8.1.1 Asia Pacific Immunosuppressive Drugs Sales by Type (2017-2028)
- 8.1.2 Asia Pacific Immunosuppressive Drugs Revenue by Type (2017-2028)
- 8.2 Asia Pacific Immunosuppressive Drugs Market Size by Application
- 8.2.1 Asia Pacific Immunosuppressive Drugs Sales by Application (2017-2028)
- 8.2.2 Asia Pacific Immunosuppressive Drugs Revenue by Application (2017-2028)
- 8.3 Asia Pacific Immunosuppressive Drugs Market Size by Region
- 8.3.1 Asia Pacific Immunosuppressive Drugs Sales by Region (2017-2028)
- 8.3.2 Asia Pacific Immunosuppressive Drugs Revenue by Region (2017-2028)
- 8.3.3 China
- 8.3.4 Japan
- 8.3.5 South Korea
- 8.3.6 India
- 8.3.7 Australia
- 8.3.8 China Taiwan
- 8.3.9 Indonesia
- 8.3.10 Thailand
- 8.3.11 Malaysia
9 Latin America
- 9.1 Latin America Immunosuppressive Drugs Market Size by Type
- 9.1.1 Latin America Immunosuppressive Drugs Sales by Type (2017-2028)
- 9.1.2 Latin America Immunosuppressive Drugs Revenue by Type (2017-2028)
- 9.2 Latin America Immunosuppressive Drugs Market Size by Application
- 9.2.1 Latin America Immunosuppressive Drugs Sales by Application (2017-2028)
- 9.2.2 Latin America Immunosuppressive Drugs Revenue by Application (2017-2028)
- 9.3 Latin America Immunosuppressive Drugs Market Size by Country
- 9.3.1 Latin America Immunosuppressive Drugs Sales by Country (2017-2028)
- 9.3.2 Latin America Immunosuppressive Drugs Revenue by Country (2017-2028)
- 9.3.3 Mexico
- 9.3.4 Brazil
- 9.3.5 Argentina
10 Middle East and Africa
- 10.1 Middle East and Africa Immunosuppressive Drugs Market Size by Type
- 10.1.1 Middle East and Africa Immunosuppressive Drugs Sales by Type (2017-2028)
- 10.1.2 Middle East and Africa Immunosuppressive Drugs Revenue by Type (2017-2028)
- 10.2 Middle East and Africa Immunosuppressive Drugs Market Size by Application
- 10.2.1 Middle East and Africa Immunosuppressive Drugs Sales by Application (2017-2028)
- 10.2.2 Middle East and Africa Immunosuppressive Drugs Revenue by Application (2017-2028)
- 10.3 Middle East and Africa Immunosuppressive Drugs Market Size by Country
- 10.3.1 Middle East and Africa Immunosuppressive Drugs Sales by Country (2017-2028)
- 10.3.2 Middle East and Africa Immunosuppressive Drugs Revenue by Country (2017-2028)
- 10.3.3 Turkey
- 10.3.4 Saudi Arabia
11 Company Profiles
- 11.1 Pfizer
- 11.1.1 Pfizer Corporation Information
- 11.1.2 Pfizer Overview
- 11.1.3 Pfizer Immunosuppressive Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.1.4 Pfizer Immunosuppressive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
- 11.1.5 Pfizer Recent Developments
- 11.2 Sanofi
- 11.2.1 Sanofi Corporation Information
- 11.2.2 Sanofi Overview
- 11.2.3 Sanofi Immunosuppressive Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.2.4 Sanofi Immunosuppressive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
- 11.2.5 Sanofi Recent Developments
- 11.3 Novartis
- 11.3.1 Novartis Corporation Information
- 11.3.2 Novartis Overview
- 11.3.3 Novartis Immunosuppressive Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.3.4 Novartis Immunosuppressive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
- 11.3.5 Novartis Recent Developments
- 11.4 Roche
- 11.4.1 Roche Corporation Information
- 11.4.2 Roche Overview
- 11.4.3 Roche Immunosuppressive Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.4.4 Roche Immunosuppressive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
- 11.4.5 Roche Recent Developments
- 11.5 Astellas Pharma, Inc.
- 11.5.1 Astellas Pharma, Inc. Corporation Information
- 11.5.2 Astellas Pharma, Inc. Overview
- 11.5.3 Astellas Pharma, Inc. Immunosuppressive Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.5.4 Astellas Pharma, Inc. Immunosuppressive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
- 11.5.5 Astellas Pharma, Inc. Recent Developments
- 11.6 GlaxoSmithKline plc
- 11.6.1 GlaxoSmithKline plc Corporation Information
- 11.6.2 GlaxoSmithKline plc Overview
- 11.6.3 GlaxoSmithKline plc Immunosuppressive Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.6.4 GlaxoSmithKline plc Immunosuppressive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
- 11.6.5 GlaxoSmithKline plc Recent Developments
- 11.7 Veloxis Pharmaceuticals
- 11.7.1 Veloxis Pharmaceuticals Corporation Information
- 11.7.2 Veloxis Pharmaceuticals Overview
- 11.7.3 Veloxis Pharmaceuticals Immunosuppressive Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.7.4 Veloxis Pharmaceuticals Immunosuppressive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
- 11.7.5 Veloxis Pharmaceuticals Recent Developments
- 11.8 Mylan
- 11.8.1 Mylan Corporation Information
- 11.8.2 Mylan Overview
- 11.8.3 Mylan Immunosuppressive Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.8.4 Mylan Immunosuppressive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
- 11.8.5 Mylan Recent Developments
- 11.9 Dr Reddys Laboratories
- 11.9.1 Dr Reddys Laboratories Corporation Information
- 11.9.2 Dr Reddys Laboratories Overview
- 11.9.3 Dr Reddys Laboratories Immunosuppressive Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.9.4 Dr Reddys Laboratories Immunosuppressive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
- 11.9.5 Dr Reddys Laboratories Recent Developments
- 11.10 Abbvie Inc
- 11.10.1 Abbvie Inc Corporation Information
- 11.10.2 Abbvie Inc Overview
- 11.10.3 Abbvie Inc Immunosuppressive Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.10.4 Abbvie Inc Immunosuppressive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
- 11.10.5 Abbvie Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
- 12.1 Immunosuppressive Drugs Industry Chain Analysis
- 12.2 Immunosuppressive Drugs Key Raw Materials
- 12.2.1 Key Raw Materials
- 12.2.2 Raw Materials Key Suppliers
- 12.3 Immunosuppressive Drugs Production Mode & Process
- 12.4 Immunosuppressive Drugs Sales and Marketing
- 12.4.1 Immunosuppressive Drugs Sales Channels
- 12.4.2 Immunosuppressive Drugs Distributors
- 12.5 Immunosuppressive Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
- 13.1 Immunosuppressive Drugs Industry Trends
- 13.2 Immunosuppressive Drugs Market Drivers
- 13.3 Immunosuppressive Drugs Market Challenges
- 13.4 Immunosuppressive Drugs Market Restraints
14 Key Findings in The Global Immunosuppressive Drugs Study
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Author Details
Summary:
Get latest Market Research Reports on Immunosuppressive Drugs. Industry analysis & Market Report on Immunosuppressive Drugs is a syndicated market report, published as Global Immunosuppressive Drugs Market Insights, Forecast to 2028. It is complete Research Study and Industry Analysis of Immunosuppressive Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
